UPDATED Apr 27, 2024
Discover Australian Pharmaceuticals & Biotech Growth Stocks that are on the ASX. Sorted by forecasted growth, these Pharmaceuticals & Biotech Stocks have higher than expected earnings or sales growth compared to other companies.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
---|---|---|---|---|---|---|---|---|---|---|
GTG | AU$0.12 | -14.3% | -60.0% | AU$15.9m | n/a | PS1.5x | n/a | n/a | ||
BOD | AU$0.024 | 0% | -65.2% | AU$4.3m | n/a | PS1.3x | n/a | n/a | ||
CGB | AU$0.021 | 0% | -72.0% | AU$5.4m | n/a | PS9.7x | n/a | n/a | ||
HXL | AU$0.013 | 0% | 8.3% | AU$2.2m | n/a | PS11.2x | n/a | n/a | ||
NC6 | AU$0.021 | -4.5% | -54.3% | AU$3.6m | n/a | PS5.1x | n/a | n/a | ||
BOT | AU$0.21 | -6.7% | 144.2% | AU$330.8m | n/a | PS756.6x | n/a | n/a | ||
IXC | AU$0.08 | -3.6% | -82.4% | AU$6.0m | n/a | PS493.8x | n/a | n/a | ||
BIT | AU$0.061 | -12.9% | 110.3% | AU$55.0m | n/a | PS33.5x | n/a | n/a | ||
DXB | AU$0.32 | 10.3% | 229.9% | AU$175.9m | n/a | PS19.3x | n/a | n/a | ||
BP8 | AU$0.001 | 0% | -80.0% | AU$2.0m | n/a | PE-0.8x | n/a | n/a | ||
RGS | AU$0.013 | 160.0% | 8.3% | AU$1.5m | n/a | PS4x | n/a | n/a | ||
FRE | AU$0.062 | -21.5% | -69.0% | AU$11.1m | n/a | PS6.1x | n/a | n/a | ||
ANR | AU$0.048 | 23.1% | 60.0% | AU$8.1m | n/a | PB6.4x | n/a | n/a | ||
OSL | AU$0.004 | -33.3% | -66.7% | AU$9.0m | n/a | PS6.9x | n/a | n/a | ||
AVE | AU$0.004 | 0% | -33.3% | AU$12.7m | n/a | PS26.8x | n/a | n/a | ||
AGH | AU$0.03 | -3.2% | -43.4% | AU$12.3m | n/a | PB0.8x | n/a | n/a | ||
VLS | AU$2.24 | -4.7% | 52.4% | AU$124.9m | n/a | PE13.8x | n/a | 4.0% |